Published in J Infect Dis on January 23, 2014
Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel. BMC Med (2016) 1.46
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine. Open Forum Infect Dis (2016) 0.85
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system. Hum Vaccin Immunother (2014) 0.78
Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus. PLoS One (2016) 0.77
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. J Immunol Methods (2017) 0.75
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants. Lancet Infect Dis (2016) 0.75
The global distribution and burden of dengue. Nature (2013) 27.92
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol (2006) 7.56
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science (2002) 5.71
Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis (2012) 5.29
Enterovirus surveillance--United States, 1970-2005. MMWR Surveill Summ (2006) 4.78
Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol (2005) 4.42
Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep (2014) 4.21
Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol (2007) 3.79
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet (2007) 3.73
New strategies for the elimination of polio from India. Science (2006) 3.27
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet (2005) 3.01
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol (2007) 2.77
Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol (2002) 2.63
Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol (2004) 2.62
Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol (2003) 2.62
Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA (2004) 2.60
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Complete genome sequences of all members of the species Human enterovirus A. J Gen Virol (2004) 2.47
Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol (2004) 2.44
Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull World Health Organ (2002) 2.43
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol (2003) 2.40
A global call for new polio vaccines. Nature (2005) 2.26
Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. J Gen Virol (2005) 2.22
Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med (2010) 2.21
Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci U S A (2008) 2.11
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. Lancet Infect Dis (2011) 2.06
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis (2009) 2.05
Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J Gen Virol (2006) 2.04
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother (2007) 2.03
Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75. J Gen Virol (2004) 2.02
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ (2004) 1.90
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med (2014) 1.87
Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis (2003) 1.79
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis (2007) 1.76
Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis (2010) 1.75
A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005. J Infect Dis (2008) 1.75
Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol (2004) 1.73
The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog (2011) 1.70
Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J Clin Microbiol (2009) 1.69
RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. J Virol (2004) 1.68
Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. J Gen Virol (2009) 1.67
Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS One (2012) 1.64
Detection of all known parechoviruses by real-time PCR. J Clin Microbiol (2008) 1.61
A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med (2011) 1.61
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest (2013) 1.60
"Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics (2013) 1.57
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Molecular phylogeny and proposed classification of the simian picornaviruses. J Virol (2002) 1.55
First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. Pediatr Infect Dis J (2015) 1.54
Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol (2005) 1.52
Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med (2008) 1.49
Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B. Virus Res (2007) 1.48
Economic analysis of the global polio eradication initiative. Vaccine (2010) 1.47
Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog (2010) 1.46
An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. Clin Infect Dis (2008) 1.45
Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr Infect Dis J (2006) 1.44
Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor. Int J Epidemiol (2003) 1.44
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Forecasting high-priority infectious disease surveillance regions: a socioeconomic model. Clin Infect Dis (2012) 1.42
ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J (2011) 1.35
Geographic variation in the relationship between human Lyme disease incidence and density of infected host-seeking Ixodes scapularis nymphs in the Eastern United States. Am J Trop Med Hyg (2012) 1.34
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis (2008) 1.34
Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis (2012) 1.32
Viral and bacterial causes of severe acute respiratory illness among children aged less than 5 years in a high malaria prevalence area of western Kenya, 2007-2010. Pediatr Infect Dis J (2013) 1.31
A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel (2009) 1.29
Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis (2010) 1.28
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ (2004) 1.28
Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep (2014) 1.27
Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae. Virology (2003) 1.27
Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol (2003) 1.26
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. Am J Epidemiol (2005) 1.25
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol (2003) 1.25
Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J Gen Virol (2010) 1.23
Characterizing the picornavirus landscape among synanthropic nonhuman primates in Bangladesh, 2007 to 2008. J Virol (2012) 1.23
Policy. OPV cessation--the final step to a "polio-free" world. Science (2005) 1.19